6669 — Acotec Scientific Holdings Income Statement
0.000.00%
Last trade - 00:00
- HK$2.27bn
- HK$1.58bn
- CNY473.85m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 125 | 194 | 304 | 396 | 474 |
Cost of Revenue | |||||
Gross Profit | 106 | 164 | 266 | 336 | 377 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 97.7 | 224 | 367 | 323 | 449 |
Operating Profit | 27.2 | -30 | -63.4 | 72.1 | 25 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 26.7 | -31.4 | -67.2 | 70.3 | 14.5 |
Provision for Income Taxes | |||||
Net Income After Taxes | 23.1 | -44.3 | -79.1 | 70.1 | 14.5 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 23.1 | -43.8 | -79.1 | 70.1 | 14.5 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 23.1 | -43.8 | -79.1 | 70.1 | 14.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.072 | -0.116 | -0.211 | 0.234 | 0.048 |